Skip to Content

W 271 (Lamotrigine Extended-Release 25 mg)

Pill with imprint W 271 is Yellow, Round and has been identified as Lamotrigine Extended-Release 25 mg. It is supplied by Wockhardt USA LLC.

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for W 271

Lamotrigine extended-release 25 mg W 271

Lamotrigine Extended-Release

Imprint
W 271
Strength
25 mg
Color
Yellow
Size
10.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Wockhardt USA LLC
National Drug Code (NDC)
64679-0271
Inactive Ingredients
diethyl phthalate, ferric oxide yellow, hypromelloses, lactose monohydrate, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polyethylene glycol, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "W 271"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.